Good Clinical Practice & Pharmacovigilance Compliance Symposium Day One - AM

Поделиться
HTML-код
  • Опубликовано: 22 окт 2024
  • This Joint US-FDA, MHRA-UK, Health Canada workshop focused on Global Clinical Trials in Good Clinical Practice, Bioequivalence, and Pharmacovigilance in the post pandemic world. Panelists discussed continuing developments in novel operational approaches, data sources, and technologies used in clinicals trials, as well as novel approaches to regulatory inspections.
    Timestamps
    00:01 - Day One Opening Remarks & Keynote
    13:05 - Session 1: Good Clinical Practice (GCP) Harmonization: Updates to ICH E6(R3)
    01:02:31 - Session 2: Technology in Clinical Trials - Digital Health Technology (DHT)
    01:45:41 - Session 3: Clinical Trials with Decentralized Elements and GCP Inspections
    Day One Keynote Speaker:
    Patrizia Cavazzoni, MD
    Director
    Center for Drug Evaluation & Research (CDER) | FDA
    Speakers | Panelists:
    Kassa Ayalew, MD, MPH
    Division Director
    Division of Clinical Compliance Evaluation (DCCE)
    Office of Scientific Investigations (OSI)
    Office of Compliance (OC)
    CDER | FDA
    Leigh Marcus, MD
    Senior Physician
    DCCE | OSI | OC | CDER | FDA
    Hocine Abid, MD, MBA
    National Manager
    Regulatory Operations and Enforcement Branch (ROEB)
    Health Canada (HC)
    Andrew Fisher, BSc
    Lead Senior Good Clinical Practice (GCP) Inspector
    Medicines and Healthcare products Regulatory Agency (MHRA)
    Debbi Fox, BSc
    Compliance Specialist
    ROEB | HC
    Elena Boley, MD, MBA
    Senior Physician
    DCCE | OSI | OC | CDER | FDA
    Mandy Budwal-Jagait, MSc
    Head of GCP and Lead Senior GCP Inspector
    MHRA
    Karen Bleich, MD
    Lead Physician
    Division of Clinical Trial Quality (DCTQ)
    Office of Medical Policy Initiatives (OMPI)
    Office of Medical Policy (OPM)
    CDER | FDA
    Lee Pai-Scherf, MD
    Senior Medical Officer
    Good Clinical Practice Assessment Branch (GCPAB)
    DCCE | OSI | OC | CDER | FDA
    Alicja Kasina, MSc
    Senior Regulatory Advisor
    ROEB | HC
    Hayley Dixey, BSc
    Lead Senior GCP Inspector
    MHRA
    Learn more at: www.fda.gov/dr...
    -----------------------
    FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
    Upcoming Training - www.fda.gov/cd...
    SBIA Listserv - public.govdeli...
    SBIA 2022 Playlist - • 2022 CDER Small Busine...
    SBIA LinkedIn -  / cder-small-business-an...
    SBIA Training Resources - www.fda.gov/cd...
    Twitter -  / fda_drug_info
    Email - CDERSBIA@fda.hhs.gov
    Phone - (301) 796-6707 I (866) 405-5367

Комментарии •